dulaglutide
Marketedupdated 2mo agoby Eli Lilly and Co
Approvedannual revenue · 2024–2024peak $5.3B
community read0 votes
Protein drug with a maximum clinical stage of Approval (across all indications), with an approval for diabetes mellitus and type 2 diabetes mellitus and 4 investigational indications.
indications
investigational
Type 2 Diabetes
all catalysts(22)
approval · 22
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that